PharmaShots | Incisive News in 3 Shots

Subscribe Now

METex14 Skipping Alterations

Merck KGaA's Tepmetko (tepotinib) Receives the Japanese MHLW's Approval for Advanced NSCLC with METex14 Skipping Alterations

Merck KGaA's Tepmetko (tepotinib) Receives the Japanese MHLW's Approval for Advanced NSCLC with METex14 Skipping Alterations

March 25, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us